Use of beta-2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease Dr. Jeffrey Ratliff talks with Dr. Franziska Hopfner about her paper on the use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease July 9, 2019 Issue Neurology, Journal, podcast Listen23:47 Disclosures View Recent Podcasts
